NO20033722L - Aktuatorer for trykksatte inhalatorer for tilmålt dose og produkter for medisinsk aerosollösningsformulering omfattende disse aktuatorer - Google Patents

Aktuatorer for trykksatte inhalatorer for tilmålt dose og produkter for medisinsk aerosollösningsformulering omfattende disse aktuatorer

Info

Publication number
NO20033722L
NO20033722L NO20033722A NO20033722A NO20033722L NO 20033722 L NO20033722 L NO 20033722L NO 20033722 A NO20033722 A NO 20033722A NO 20033722 A NO20033722 A NO 20033722A NO 20033722 L NO20033722 L NO 20033722L
Authority
NO
Norway
Prior art keywords
actuators
metered dose
solution formulation
dose inhalers
pressurized metered
Prior art date
Application number
NO20033722A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033722D0 (no
Inventor
Rebecca Jayne Davies
David Ganderton
David Andrew Lewis
Brian John Meakin
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20033722D0 publication Critical patent/NO20033722D0/no
Publication of NO20033722L publication Critical patent/NO20033722L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
NO20033722A 2001-12-21 2003-08-21 Aktuatorer for trykksatte inhalatorer for tilmålt dose og produkter for medisinsk aerosollösningsformulering omfattende disse aktuatorer NO20033722L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01130521A EP1321159A1 (fr) 2001-12-21 2001-12-21 Dispositif d'actionnement pour inhalateur doseur pressurisé avec orifices percés par laser
PCT/EP2002/014588 WO2003053501A1 (fr) 2001-12-21 2002-12-19 Aerosol-doseur

Publications (2)

Publication Number Publication Date
NO20033722D0 NO20033722D0 (no) 2003-08-21
NO20033722L true NO20033722L (no) 2003-10-20

Family

ID=8179630

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033722A NO20033722L (no) 2001-12-21 2003-08-21 Aktuatorer for trykksatte inhalatorer for tilmålt dose og produkter for medisinsk aerosollösningsformulering omfattende disse aktuatorer

Country Status (16)

Country Link
US (2) US20050061314A1 (fr)
EP (3) EP1321159A1 (fr)
JP (2) JP2005512691A (fr)
AU (2) AU2002361179B2 (fr)
BR (1) BR0207631A (fr)
CA (1) CA2470857A1 (fr)
EA (1) EA006754B1 (fr)
GE (1) GEP20064002B (fr)
HR (1) HRP20040559A2 (fr)
HU (1) HUP0402487A2 (fr)
NO (1) NO20033722L (fr)
NZ (1) NZ534040A (fr)
PL (1) PL369072A1 (fr)
UA (1) UA75770C2 (fr)
WO (2) WO2003053501A1 (fr)
YU (1) YU64804A (fr)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
KR101008609B1 (ko) * 2002-08-14 2011-01-17 지더블유 파마 리미티드 점막투여용 칸나비노이드 액체 제형
BRPI0414428A (pt) * 2003-09-15 2006-11-14 Vectura Ltd composições farmacêuticas
DK1768490T3 (da) 2004-10-07 2010-10-11 Transmedics Inc Systemer og fremgangsmåder til ex-vivo-organpleje
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
CN101203208A (zh) * 2005-06-20 2008-06-18 尤尼麦德制药公司 屈大麻酚治疗偏头痛
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
AU2006330943A1 (en) * 2005-12-21 2007-07-05 N30 Pharmaceuticals, Llc Stable S-nitrosothiol formulations
DE102006014433A1 (de) * 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
DE102006022002A1 (de) * 2006-05-10 2007-11-15 Boehringer Ingelheim International Gmbh Zerstäuber und Verfahren zur Zerstäubung von Fluid
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
US8062685B2 (en) * 2007-04-03 2011-11-22 Frito-Lay North America, Inc. Direct expanded snack made with peanut flour and method for making
EP2144653B1 (fr) * 2007-05-10 2018-11-28 3M Innovative Properties Company Fabrication de composants de valve doseuse
EP2011534A1 (fr) * 2007-07-03 2009-01-07 CHIESI FARMACEUTICI S.p.A. Actionneur d'inhalateur à dosage mesuré
EP2011537A1 (fr) * 2007-07-06 2009-01-07 Vectura Delivery Devices Limited Inhalateur
US20090151722A1 (en) * 2007-07-06 2009-06-18 Vectura Delivery Devices Limited Inhaler
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2080507A1 (fr) 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Formulations pharmaceutiques comprenant un médicament anticholinérgique
US9814230B2 (en) 2008-01-31 2017-11-14 Transmedics, Inc. Systems and methods for ex vivo lung care
CA2683353C (fr) 2008-10-22 2015-12-15 Trudell Medical International Systeme modulaire d'administration d'aerosol
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
WO2011064164A1 (fr) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nébuliseur
WO2011064163A1 (fr) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nébuliseur
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011076841A2 (fr) 2009-12-23 2011-06-30 Chiesi Farmaceutici S.P.A. Polythérapie destinée à la bronchopneumopathie chronique obstructive
CN104055765B (zh) 2009-12-23 2016-11-23 奇斯药制品公司 用于copd的联合治疗
EP2515856B1 (fr) 2009-12-23 2014-04-02 Chiesi Farmaceutici S.p.A. Formule d'aérosol pour COPD
GEP20166479B (en) 2009-12-23 2016-05-25 Chiesi Farma Spa Aerosol formulation for copd
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
AU2011278693B2 (en) * 2010-07-12 2015-02-19 Xellia Pharmaceuticals Aps Treatment of lung infections by administration of Tobramycin by aerolisation
WO2012130757A1 (fr) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Appareil médical pourvu d'un récipient
EP4032401A1 (fr) 2011-04-14 2022-07-27 Transmedics, Inc. Solution ocs pour perfusion ex vivo de greffons pulmonaires
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013114374A1 (fr) 2012-02-01 2013-08-08 Protalix Ltd. Polypeptides d'adnase i, polynucléotides codant ces derniers, procédés de production d'adnase i et utilisations de celle-ci en thérapie
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
CN104582771B (zh) 2012-08-29 2018-09-04 奇斯药制品公司 气溶胶吸入装置
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
WO2015018904A1 (fr) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nébuliseur
USD772395S1 (en) * 2013-11-29 2016-11-22 Norton (Waterford) Limited Respiratory apparatus
EA033227B1 (ru) 2013-12-30 2019-09-30 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Находящаяся под давлением стабильная аэрозольная композиция комбинации гликопиррония бромида и формотерола в форме раствора
GB2524469A (en) * 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor
US9918961B2 (en) 2014-02-19 2018-03-20 Kind Consumer Limited Cannabinoid inhaler and composition therefor
EP3139984B1 (fr) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nébuliseur
KR102443737B1 (ko) 2014-05-07 2022-09-19 베링거 인겔하임 인터내셔날 게엠베하 컨테이너, 분무기 및 사용 방법
KR20230018542A (ko) 2014-05-07 2023-02-07 베링거 인겔하임 인터내셔날 게엠베하 분무기, 표시 디바이스 및 컨테이너
CN106659151B (zh) 2014-06-02 2021-06-08 特兰斯迈迪茨公司 离体器官护理系统
US20160151275A1 (en) * 2014-06-16 2016-06-02 James Kevin Shurtleff Method and devices for manufacturing and delivering of aerosolized formulations
US10610512B2 (en) 2014-06-26 2020-04-07 Island Breeze Systems Ca, Llc MDI related products and methods of use
WO2016057693A1 (fr) 2014-10-10 2016-04-14 Alnylam Pharmaceuticals, Inc. Procédés et compositions pour administration par inhalation d'oligonucléotide conjugué
BR112017010520B1 (pt) 2014-12-12 2022-08-30 Tevosol, Inc Aparelho e método para perfusão de órgãos
WO2016187156A1 (fr) * 2015-05-21 2016-11-24 Island Breeze Systems Ca, Llc Inhalateur à base d'agent propulseur à dose mesurée et applicateurs alimentaires et applicateurs correspondants
EP3347084B1 (fr) 2015-09-09 2020-11-11 Transmedics, Inc. Canule aortique pour système de traitement ex vivo d'organe
GB2544477A (en) * 2015-11-16 2017-05-24 3M Innovative Properties Co Improvements in or relating to medical actuators
EP3436115B1 (fr) 2016-03-31 2021-07-28 Chiesi Farmaceutici S.p.A. Dispositif d'inhalation d'aérosol
US9717683B1 (en) 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
US10098837B2 (en) 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD
US10231948B2 (en) 2017-02-27 2019-03-19 Jason Ty Nguyen Metered dose inhaler compositions, systems, and methods
US10906728B2 (en) * 2017-06-20 2021-02-02 Aptar France Sas Device for dispensing a fluid product
GB2567240B (en) 2017-10-09 2022-04-06 Senzer Ltd An inhaler particularly a cannabinoid inhaler and a method of assembling such an inhaler
EP3797964B1 (fr) 2019-09-26 2023-06-07 Presspart Manufacturing S.A. Outil de moulage par injection pour inhalateur de dose mesurée
GB2595692A (en) 2020-06-03 2021-12-08 Senzer Ltd A refill for an inhaler particularly a cannabinoid inhaler
WO2021247283A1 (fr) * 2020-06-04 2021-12-09 Amcyte Pharma, Inc. Administration de concentrations micromolaires de composition en aérosol

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279824A (en) * 1979-11-01 1981-07-21 Mckinney Laurence O Method and apparatus for processing herbaceous plant materials including the plant cannabis
DE3305755A1 (de) 1983-02-19 1984-08-23 Gödecke AG, 1000 Berlin N-phenyl-benzamid-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkranungen des immunsystems
US5290539A (en) 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
GB2276101A (en) 1993-03-19 1994-09-21 Csb Moulds Ltd Spray nozzles for pharmaceutical inhalers
US5389375A (en) * 1993-05-21 1995-02-14 University Of Mississippi Stable suppository formulations effecting bioavailability of Δ9 -thc
US5464154A (en) * 1993-09-29 1995-11-07 Union Carbide Chemicals & Plastics Technology Corporation Methods for spraying polymeric compositions with compressed fluids and enhanced atomization
DK1011646T3 (da) * 1996-12-04 2005-09-19 Link Products Ltd Farmaceutiske præparater og indretninger til administration heraf
BR7702049U (pt) 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
JP2002512871A (ja) 1998-04-30 2002-05-08 スリーエム イノベイティブ プロパティズ カンパニー 製薬エアロゾル用定量弁
US6008383A (en) 1998-10-26 1999-12-28 University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol esters
US6509005B1 (en) 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6209286B1 (en) * 1999-03-09 2001-04-03 Novus Packaging Corporation Machine and method for manufacturing a continuous production of pneumatically filled inflatable packaging pillows
DE60031504T2 (de) * 1999-09-11 2007-04-05 Glaxo Group Ltd., Greenford Fluticasonpropionat arzneizubereitung
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.

Also Published As

Publication number Publication date
JP2005512691A (ja) 2005-05-12
EA200400730A1 (ru) 2005-02-24
WO2003053501A1 (fr) 2003-07-03
UA75770C2 (en) 2006-05-15
YU64804A (sh) 2006-05-25
WO2003055549A1 (fr) 2003-07-10
EA006754B1 (ru) 2006-04-28
HUP0402487A2 (hu) 2005-06-28
PL369072A1 (en) 2005-04-18
US20080017191A1 (en) 2008-01-24
AU2002361179B2 (en) 2007-10-25
GEP20064002B (en) 2006-12-25
NO20033722D0 (no) 2003-08-21
HRP20040559A2 (en) 2004-10-31
BR0207631A (pt) 2004-06-01
US20050061314A1 (en) 2005-03-24
AU2002361453A1 (en) 2003-07-15
EP1455873A1 (fr) 2004-09-15
NZ534040A (en) 2006-03-31
CA2470857A1 (fr) 2003-07-03
EP1321159A1 (fr) 2003-06-25
EP1455874A1 (fr) 2004-09-15
AU2002361179A1 (en) 2003-07-09
JP2005512740A (ja) 2005-05-12

Similar Documents

Publication Publication Date Title
NO20033722L (no) Aktuatorer for trykksatte inhalatorer for tilmålt dose og produkter for medisinsk aerosollösningsformulering omfattende disse aktuatorer
DK1306082T3 (da) Afmålte dosisinhalatorer under tryk og farmaceutiske aerosolformuleringer
HUS1800032I1 (hu) Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
DK1397174T3 (da) Pulverformulerings-desintegrationssystem og tørpulverinhalatorer
ITMI20000300A0 (it) Nebulizzatore medico per liquido da utilizzare nella terapia respiratoria e altre applicazioni
ITMI20000010A0 (it) Dispositivo per la somministrazione di aerosol dosati pressurizzati in propellenti idrofluoroalcani
NO20026055D0 (no) Farmasöytisk komponent omfattende human paratyroidhormon og farmasöytisk komponent for nasal administrering inneholdende komponentene
NO20013141D0 (no) Arylalkanoylderivater, fremgangsmåte for fremstilling derav, deres anvendelse og farmasöytiske produkter inneholdende disse
IL152751A0 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
GB0106018D0 (en) Pharmaceutical aerosol formulation
GB0128335D0 (en) Pharmaceutical aerosol formulation
PT1181197E (pt) Embalagem para um produto farmaceutico e metodo para esterilizar a embalagem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application